| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/04/2005 | CN1612942A Viral capsid assembly intermediates |
| 05/04/2005 | CN1612929A Allene oxide synthase and divinyl ether synthase from the C Y P 7 4-enzyme family isolated out of physcomitrella patens, the nucleotide sequences that code these synthases, and method for producing pa |
| 05/04/2005 | CN1612896A Peptide purification by means of metal ion affinity chromatography |
| 05/04/2005 | CN1612890A Novel chimeric tnf ligands |
| 05/04/2005 | CN1612717A Method and apparatus for production of a skin graft and the graft produced thereby |
| 05/04/2005 | CN1612691A Methods and compositions for correction of cardiac conduction disturbances |
| 05/04/2005 | CN1611605A Method for producing human leukemia inhibitory factor using transgenic plant |
| 05/04/2005 | CN1611599A Method for inducing stem cell to liver cell directional diferentiation and use of liver cell |
| 05/04/2005 | CN1611598A Human foetus pancreatic stem cell line and its establishing method |
| 05/04/2005 | CN1611597A Rat marrow MSC invivo transplanting directional differentiation into retina structure |
| 05/04/2005 | CN1611227A Egg white activity aspiration extraction and activity measuring technique |
| 05/04/2005 | CN1200107C Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
| 05/04/2005 | CN1200105C Homocysteine desulphurase from the protozoan trichomonas vaginalis |
| 05/04/2005 | CN1199697C Method for producing bio-artificial transplant |
| 05/04/2005 | CN1199567C Hybrid matrix implants and explants |
| 05/03/2005 | US6887987 DNA encoding the human serine protease T |
| 05/03/2005 | US6887983 Purified 20 kDA presenilin 2 C-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2 |
| 05/03/2005 | US6887981 Natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 05/03/2005 | US6887978 Vanilloid receptor |
| 05/03/2005 | US6887975 Serpentine protein for use in the treatment of cancer |
| 05/03/2005 | US6887843 Chlamydia protein, gene sequence and uses thereof |
| 05/03/2005 | US6887706 Method of in vitro differentiation of transplantable neural precursor cells from primate embryonic stem cells |
| 05/03/2005 | US6887705 For inducing polymerization of actin monomers in eukaryotic cells; drug screening; genetic engineering; phosphorylation/dephosphorylation |
| 05/03/2005 | US6887704 A cell population cultured ex-vivo in a culture medium under conditions permitting cells of cell population to proliferate and at the same time reducing capacity of cells in utilizing copper, hence expanded yet not further differentiated |
| 05/03/2005 | US6887698 Nucleotide sequences coding polypeptides for use in the generation of preferential mucopolysaccharides |
| 05/03/2005 | US6887683 Human G-protein coupled receptors |
| 05/03/2005 | US6887680 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
| 05/03/2005 | US6887674 Artery- and vein-specific proteins and uses therefor |
| 05/03/2005 | US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering |
| 05/03/2005 | US6887661 Recombinant bHLH-PAS/JHR polypeptide and its use to screen potential insecticides |
| 05/03/2005 | US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 05/03/2005 | US6887488 Nano-calcium phosphates/collagen based bone substitute materials |
| 05/03/2005 | US6887475 Administering isolated Notch ligand comprising a DSL domain, wherein isolated Notch ligand is Serrate, wherein isolated Notch ligand interacts with a Notch receptor, wherein T-cell activation occurs with allergy or graft rejection |
| 05/03/2005 | US6887472 That do not cause anaphylaxis, antigenic fusion proteins of given amino acid sequence, of a CH3 domain of an immunoglobulin (IgE) molecule; allergy vaccines; vaccine test methods in dogs |
| 05/03/2005 | US6887468 Antibody kits for selectively inhibiting VEGF |
| 05/03/2005 | US6887466 Activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand; HIV immunotherapy; T cells can be genetically transduced and used for immunotherapy |
| 05/03/2005 | US6887463 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia |
| 05/03/2005 | US6886568 Method for fabricating cell-containing implants |
| 05/03/2005 | CA2303408C Chromosomal mutagenesis in pichia methanolica |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 04/30/2005 | CA2486322A1 Printing growth medium for culture and analysis of biological material |
| 04/28/2005 | WO2005038454A1 In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (bmp) and/or circulation precursor cells derived from blood (bdp) |
| 04/28/2005 | WO2005038020A1 Flp-mediated recombination |
| 04/28/2005 | WO2005038016A1 Cartilage replacement implant and method for producing a cartilage replacement implant |
| 04/28/2005 | WO2005038015A1 Human corneal endothelial cells and methods of obtaining and culturing cells for corneal cell transplantation |
| 04/28/2005 | WO2005038014A1 Isolation of stem cell-like cells and use thereof |
| 04/28/2005 | WO2005038012A2 Cartilage and bone repair and regeneration using postpartum-derived cells |
| 04/28/2005 | WO2005038011A1 Method of constructing artificial cell tissue and base material therefor |
| 04/28/2005 | WO2005038010A2 Control of es cell self-renewal and lineage specification, and medium therefor |
| 04/28/2005 | WO2005037996A2 In vitro development of tissues and organs |
| 04/28/2005 | WO2005037986A1 Cultured cell sheet package |
| 04/28/2005 | WO2005037985A2 Composition and methods for cell culturing and tissue culture platforms |
| 04/28/2005 | WO2005037984A1 Cell handling device, human tissue regeneration composition, and human tissue regeneration method |
| 04/28/2005 | WO2005037863A2 Alternative splicing factors polynucleotides, polypeptides and uses thereof |
| 04/28/2005 | WO2005037309A1 A method for increasing cd8+ cytotoxic t cell reponses and for treating multiple sclerosis |
| 04/28/2005 | WO2005037225A2 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 04/28/2005 | WO2005037190A2 Multiplex vaccines |
| 04/28/2005 | WO2005037144A2 Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants |
| 04/28/2005 | WO2005015151A3 Method for purifying mesenchymal stem cells |
| 04/28/2005 | WO2005010160A3 Liquid crystals with reduced toxicity and applications thereof |
| 04/28/2005 | WO2005007811A3 Injection of bone marrow-derived cells and medium for angiogenesis |
| 04/28/2005 | WO2005001079A3 Soft tissue repair and regeneration using postpartum-derived cells |
| 04/28/2005 | WO2004113511A3 Cell line and uses thereof |
| 04/28/2005 | WO2004099251A3 Compositions and methods for treatment of cryptococcosis |
| 04/28/2005 | WO2004098531A3 Increased transduction using abc transporter substrates and/or inhibitors |
| 04/28/2005 | WO2004098492A3 Trans-golgi network-associated processes, methods and compositions related thereto |
| 04/28/2005 | WO2004048531A3 Modulation of death-associated protein kinase 1 expression |
| 04/28/2005 | WO2004048524A3 Modulation of stat2 expression |
| 04/28/2005 | WO2004037188A3 Cardiac muscle regeneration using mesenchymal stem cells |
| 04/28/2005 | WO2004020601A3 Neurogenesis from hepatic stem cells |
| 04/28/2005 | WO2003104411A3 Bioartificial liver system |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003095971A3 Posh nucleic acids, polypeptides and related methods |
| 04/28/2005 | WO2003087392A3 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | WO2003041568A3 A three-dimensional matrix for producing living tissue equivalents |
| 04/28/2005 | WO2002072013A8 Method of treating malignancies through induction of blood immune responses |
| 04/28/2005 | US20050091713 Nucleic acid nematicides |
| 04/28/2005 | US20050091712 Platn growth regulator(s) comprising auxins, cytokinins, indoleacetic acid, indolebutyric acid, naphthaleneacetic acid, 6-benzylaminopurine, gamma-gamma-dimethyl allylamino purine, isopentinyl adenine and/or kinetin with vitamins, minerals, and soluble polyvinylpyrrolidone; scents |
| 04/28/2005 | US20050091711 isolated by identifying and analyzing genes of Arabidopsis thaliana; trichome is involved in secretion and excretion from the surface of a plant body |
| 04/28/2005 | US20050091709 Transgenic organism epressing fungal mrp-like abc transporters |
| 04/28/2005 | US20050091704 transgenic mouse in which the Ant2 gene is inactivated in the liver; thought to be an integral component of the mitochondrial permeability transition pore |
| 04/28/2005 | US20050091702 Expression of polypeptides in rod outer segment membranes |
| 04/28/2005 | US20050090803 Microstructures for treating and conditioning skin |
| 04/28/2005 | US20050090658 Comprises polymorphic variations/point mutations linked to cation channel dysfunctions; genetic engineering; treansgenic animal; antibody |
| 04/28/2005 | US20050090647 Pharmaceutical compositions for treating arthritis and inflammatory disease |
| 04/28/2005 | US20050090464 Vectors for enhanced expression of Vegf for disease treatment |
| 04/28/2005 | US20050090461 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents |
| 04/28/2005 | US20050090441 inducing prolonged in vivo gene expression in mammal by contacting nonmuscular tissue with a nucleic acid, a histone, and an amphipathic compound; animal models: |
| 04/28/2005 | US20050090007 To produce human proteins in economical yields and in a form which is suitable for the production of a pharmaceutical preparation |
| 04/28/2005 | US20050090005 Apparatus for culture, process for preparing apparatus for culture, and culturing method |
| 04/28/2005 | US20050090004 Stem cell maturation for all tissue lines |
| 04/28/2005 | US20050090003 Genetically-modified, non-human mammal, wherein the genome of the mammal comprises a genetic modification to a copy of the P2x7R gene that results in disrupted P2x7R gene function from the modified gene |
| 04/28/2005 | US20050090002 Serum free medium for chondrocyte-like cells |
| 04/28/2005 | US20050090001 Cell lines and methods for producing proteins |
| 04/28/2005 | US20050089999 Method for the production and purification of adenoviral vectors |
| 04/28/2005 | US20050089985 Rescue of canine distemper virus from cdna |
| 04/28/2005 | US20050089984 Having a specific amino acid sequence, especially fused to a heterologous polypeptide; induces apoptosis |
| 04/28/2005 | US20050089981 Cucleic acid cotnaining a specific nucleotide sequence which encodes a polypeptide which elongates alpha -linolenic acid by two or more carbon atoms whereas gamma -lino-lenic is not elongated |
| 04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |